Johnson & Johnson: Οne of the most stable businesses in the world- Μεγέθη, δείκτες μετοχής και μ.ο. Τιμής Στόχου

Johnson & Johnson is one of the most stable businesses in the world. The company has increased its adjusted earnings-per-share for 32 consecutive years.


The company has been able to achieve sustained success through diversification within the health care industry and geographical diversification. Johnson & Johnson currently generates more revenue outside the United States than inside.

The company operates in 3 large market-leading segments:

  • Consumer
  • Pharmaceuticals
  • Medical Devices

The image below shows the consistent sustained success of Johnson & Johnson:

The key brands in the company’s consumer segment are: Motrin, Tylenol, Benadryl, Zyrtec, Band-Aid, Listerine, Aveeno, Neutrogena, and Johnson’s.

It is highly likely that Johnson & Johnson will continue to deliver dividend increases year-in-and-year-out as the health care industry continues to grow.


Johnson & Johnson (JNJ)
Price 115.65
52 Week High 126.07
52 Week Low 94.28
Market Capitalization 315.54B
Avg Volume 7,132,122
Beta 0.67
Shares Short




Earnings Date 1/24/2017
Insider Ownership 0.02%
Institutional Ownership 67.3%
Analyst Price Targets – Average (15) 125.16
10 Year Dividend Growth Rate 8.0% per year
Consecutive Dividend Increases 54 years
Per share data:
EPS(TTM) 5.65
Revenue/shares(TTM) 25.62
Book Value per share (MRQ) 26.70
Cash per share (MRQ) 14.85
Dividends per share(TTM)




Dividend Yield (TTM) 2.7%
P/E 20.5
Price to Sales (TTM) 4.41
Price to Book Value (MRQ) 4.3
Long Term Debt/Equity (MRQ) 32.36
Total Debt/Equity (MRQ)

Revenue (TTM) 71.595M
EBITDA (TTM) 20.740M
Earnings Before Taxes (TTM) 19.237M
Gross Margin % (TTM) 69.6%
Net Profit Margin % (TTM) 22%
Revenue Change % (TTM) 2.2%
Revenue Change % (MRQ)-1 Year Ago 4.2%
TTM:Trailing Twelve Months
MRQ:Most Recent Quarter
Solidus Securities
Τμήμα Διεθνών Αγορών
Π. Σταυρόπουλος

Image result for solidus axepey


* ,